HealthFDA approves Gilead daily HIV pill aimed at simplifying treatment for some patients
The FDA approved a daily HIV pill from Gilead designed to simplify treatment for some patients. It is also intended for people doing well on a single-tablet regimen, including Biktarvy, who want to switch to a new treatment.
FDA approves Gilead daily HIV pill aimed at simplifying treatment for some patients
Health